Scarica l'app Stockscreener
8.07
0.12%
-0.010
Precedente Chiudi:
$8.08
Aprire:
$8.07
Volume 24 ore:
111.43K
Relative Volume:
0.08
Capitalizzazione di mercato:
$384.83M
Reddito:
-
Utile/perdita netta:
$-82.60M
Rapporto P/E:
-3.9175
EPS:
-2.06
Flusso di cassa netto:
$-48.61M
1 W Prestazione:
+0.12%
1M Prestazione:
+1.89%
6M Prestazione:
+297.54%
1 anno Prestazione:
+106.39%
Intervallo 1D:
$8.07
$8.08
Intervallo di 1 settimana:
$8.06
$8.10
Portata 52W:
$1.312
$8.10
Vigil Neuroscience Inc Stock (VIGL) Company Profile
Nome
Vigil Neuroscience Inc
Settore
Industria
Telefono
857-254-4445
Indirizzo
100 FORGE ROAD, WATERTOWN
Confronta VIGL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VIGL
Vigil Neuroscience Inc
|
8.07 | 376.64M | 0 | -82.60M | -48.61M | -2.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.33 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.16 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.74 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
573.00 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.76 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Downgrade | Stifel | Buy → Hold |
| 2024-12-04 | Iniziato | William Blair | Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-10-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-03-31 | Iniziato | Mizuho | Buy |
| 2022-09-16 | Iniziato | Wedbush | Outperform |
| 2022-08-29 | Iniziato | H.C. Wainwright | Buy |
| 2022-02-01 | Iniziato | Guggenheim | Buy |
| 2022-02-01 | Iniziato | Jefferies | Buy |
| 2022-02-01 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-02-01 | Iniziato | Stifel | Buy |
Mostra tutto
Vigil Neuroscience Inc Borsa (VIGL) Ultime notizie
What drives Vigil Neuroscience Inc. stock priceGame-changing capital returns - jammulinksnews.com
Is Vigil Neuroscience Inc. a good long term investmentStrong return on assets - jammulinksnews.com
Vigil Neuroscience Inc. Stock Analysis and ForecastFree Predictions - jammulinksnews.com
What analysts say about Vigil Neuroscience Inc. stockConsistent high-yield stocks - Autocar Professional
Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period By Investing.com - Investing.com Nigeria
Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger - TipRanks
Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period - Investing.com Australia
How Vigil Neuroscience Inc. stock performs during market volatilityIntraday Trade Ideas - Newser
Why Vigil Neuroscience Inc. stock attracts strong analyst attention10x Potential Stocks - Newser
What makes Vigil Neuroscience Inc. stock price move sharplyFree VIP Investment Strategies - Newser
Brokerages Set Vigil Neuroscience, Inc. (NASDAQ:VIGL) PT at $10.80 - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, CHTR, VIGL on Behalf of Shareholders - MarketScreener
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc.VIGL - The Globe and Mail
TREM2 agonists reported in Vigil Neuroscience patents - BioWorld MedTech
Vigil Neuroscience (NASDAQ:VIGL) Stock Price Up 0.4% – Here’s What Happened - Defense World
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: TASK, VIGL, STRM, and CHTR - The Malaysian Reserve
Vigil Neuroscience Announces Special Meeting for Sanofi Merger Vote - TipRanks
VIGL to Be Acquired by Sanofi for $8 Cash + $2 CVR; Vote Aug 4 2025 | VIGL SEC FilingForm DEFM14A - Stock Titan
Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High? - Nasdaq
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView
Two Sigma Investments LP Acquires 41,836 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders - MarketScreener
Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet - MSN
Vigil Neuroscience: ALSP Data Doesn't Deliver, But Sanofi Purchase Remains Intact (VIGL) - Seeking Alpha
Vigil Neuroscience fails in mid-stage study for lead asset - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, TASK, VIGL on Behalf of Shareholders - marketscreener.com
Vigil Neuroscience halts Phase 2 trial for ALSP treatment By Investing.com - Investing.com South Africa
Vigil’s Iluzanebart Disappoints In Rare Neurodegenerative Disease - insights.citeline.com
Vigil Neuroscience Inc Azioni (VIGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vigil Neuroscience Inc Azioni (VIGL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Magovcevic-Liebisch Ivana | President and CEO |
Dec 19 '24 |
Buy |
1.68 |
5,000 |
8,400 |
222,687 |
| Magovcevic-Liebisch Ivana | President and CEO |
Dec 18 '24 |
Buy |
1.67 |
5,000 |
8,350 |
217,687 |
| Magovcevic-Liebisch Ivana | President and CEO |
Dec 05 '24 |
Buy |
2.34 |
5,000 |
11,700 |
212,687 |
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):